 SAN DIEGO, Nov. 30, 2020 GLOBE NEWSWIRE -- Cidara Therapeutics, Inc. Nasdaq: CDTX, a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that it will present three posters at European Society of Intensive Care Medicine ESICM LIVES 2020, which takes place virtually Dec. 6-9, 2020. 